Albemarle Corporation $ALB Holdings Raised by South Dakota Investment Council

South Dakota Investment Council boosted its position in shares of Albemarle Corporation (NYSE:ALB – Free Report) by 722.9% during the third quarter, Holdings Channel.com reports. The firm owned 22,218 shares of the specialty chemicals company’s stock after buying an additional 19,518 shares during the quarter. South Dakota Investment Council’s holdings in Albemarle were worth $2,350,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Primecap Management Co. CA acquired a new stake in shares of Albemarle during the 2nd quarter worth approximately $358,101,000. ProShare Advisors LLC lifted its holdings in Albemarle by 69.7% in the third quarter. ProShare Advisors LLC now owns 1,436,117 shares of the specialty chemicals company’s stock valued at $151,912,000 after acquiring an additional 589,787 shares during the last quarter. Deutsche Bank AG acquired a new position in Albemarle in the second quarter valued at approximately $131,049,000. Amundi lifted its holdings in Albemarle by 40.5% in the second quarter. Amundi now owns 827,874 shares of the specialty chemicals company’s stock valued at $111,784,000 after acquiring an additional 238,774 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in Albemarle in the second quarter worth approximately $103,268,000. 92.87% of the stock is currently owned by institutional investors and hedge funds.

Albemarle Trading Down 3.4%

Shares of ALB stock opened at $82.87 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 2.34. The stock has a market capitalization of $9.78 billion, a P/E ratio of 20.02, a price-to-earnings-growth ratio of 0.54 and a beta of 1.34. The company has a 50 day moving average price of $100.40 and a 200 day moving average price of $143.78. Albemarle Corporation has a fifty-two week low of $82.64 and a fifty-two week high of $221.00.

Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating the consensus estimate of $2.53 by $0.05. The company had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.52 billion. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. The firm’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the company posted ($0.19) EPS. Equities research analysts predict that Albemarle Corporation will post 10.64 EPS for the current fiscal year.

Albemarle Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be issued a $0.41 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.64 annualized dividend and a yield of 2.0%. Albemarle’s dividend payout ratio (DPR) is 39.61%.

Wall Street Analysts Forecast Growth

ALB has been the topic of a number of research analyst reports. Rothschild & Co Redburn reduced their target price on Albemarle from $100.00 to $86.00 in a research report on Wednesday, November 11th. JPMorgan Chase & Co. lowered their price target on Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a report on Tuesday, August 25th. Argus cut their price objective on Albemarle from $230.00 to $135.00 and set a “buy” rating for the company in a research report on Wednesday, October 7th. Bank of America reduced their price objective on shares of Albemarle from $131.00 to $120.00 in a report on Thursday, November 12th. Finally, CICC Research upped their target price on shares of Albemarle from $83.28 to $108.58 in a research report on Wednesday, November 11th. Fifteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $152.63.

Get Our Latest Stock Report on ALB

About Albemarle

(Free Report)

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.

Featured Articles

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.